139 related articles for article (PubMed ID: 15979816)
1. Obesity and dose individualization in cancer chemotherapy: the role of body surface area and body mass index.
Portugal RD
Med Hypotheses; 2005; 65(4):748-51. PubMed ID: 15979816
[TBL] [Abstract][Full Text] [Related]
2. Body surface area in normal-weight, overweight, and obese adults. A comparison study.
Verbraecken J; Van de Heyning P; De Backer W; Van Gaal L
Metabolism; 2006 Apr; 55(4):515-24. PubMed ID: 16546483
[TBL] [Abstract][Full Text] [Related]
3. Comparison of BMI and the body mass/body surface ratio: is BMI a biased tool?
Kurbel S; Zucić D; Vrbanec D; Plestina S
Coll Antropol; 2008 Mar; 32(1):299-301. PubMed ID: 18494217
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2.
Schwartz J; Toste B; Dizon DS
Gynecol Oncol; 2009 Jul; 114(1):53-6. PubMed ID: 19359030
[TBL] [Abstract][Full Text] [Related]
5. A formula for the estimation of the body surface area of Saudi male adults.
Nwoye LO; Al-Shehri MA
Saudi Med J; 2003 Dec; 24(12):1341-6. PubMed ID: 14710281
[TBL] [Abstract][Full Text] [Related]
6. Use of body surface area for assessing extracellular fluid volume and glomerular filtration rate in obesity.
Peters AM; Glass DM
Am J Nephrol; 2010; 31(3):209-13. PubMed ID: 20029177
[TBL] [Abstract][Full Text] [Related]
7. Effect of body surface area calculations on body fat estimates in non-obese and obese subjects.
Sardinha LB; Silva AM; Minderico CS; Teixeira PJ
Physiol Meas; 2006 Nov; 27(11):1197-209. PubMed ID: 17028412
[TBL] [Abstract][Full Text] [Related]
8. Carboplatin dosing in obese women with ovarian cancer: a Gynecologic Oncology Group study.
Wright JD; Tian C; Mutch DG; Herzog TJ; Nagao S; Fujiwara K; Powell MA
Gynecol Oncol; 2008 Jun; 109(3):353-8. PubMed ID: 18407341
[TBL] [Abstract][Full Text] [Related]
9. Flat-fixed dosing versus body surface area based dosing of anticancer drugs in adults: does it make a difference?
Mathijssen RH; de Jong FA; Loos WJ; van der Bol JM; Verweij J; Sparreboom A
Oncologist; 2007 Aug; 12(8):913-23. PubMed ID: 17766650
[TBL] [Abstract][Full Text] [Related]
10. Body surface area estimation in children using weight alone: application in paediatric oncology.
Sharkey I; Boddy AV; Wallace H; Mycroft J; Hollis R; Picton S;
Br J Cancer; 2001 Jul; 85(1):23-8. PubMed ID: 11437397
[TBL] [Abstract][Full Text] [Related]
11. Obesity is not associated with increased myelosuppression in patients receiving chemotherapy for breast cancer.
Jenkins P; Elyan S; Freeman S
Eur J Cancer; 2007 Feb; 43(3):544-8. PubMed ID: 17169553
[TBL] [Abstract][Full Text] [Related]
12. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
13. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.
Dignam JJ; Polite BN; Yothers G; Raich P; Colangelo L; O'Connell MJ; Wolmark N
J Natl Cancer Inst; 2006 Nov; 98(22):1647-54. PubMed ID: 17105987
[TBL] [Abstract][Full Text] [Related]
14. Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients.
Miyahara T; Mochinaga S; Kimura S; Aragane N; Yakabe T; Morita S; Okudaira K; Fujito H
Cancer Chemother Pharmacol; 2013 Jan; 71(1):175-82. PubMed ID: 23064956
[TBL] [Abstract][Full Text] [Related]
15. L-asparaginase as a marker of chemotherapy dose modification in children with acute lymphoblastic leukemia.
Baillargeon J; Langevin AM; Lewis M; Thomas PJ; Mullins J; Dugan J; Pollock BH
Cancer; 2005 Dec; 104(12):2858-61. PubMed ID: 16288492
[TBL] [Abstract][Full Text] [Related]
16. Overweight, obesity and breast cancer prognosis: optimal body size indicator cut-points.
Majed B; Moreau T; Asselain B;
Breast Cancer Res Treat; 2009 May; 115(1):193-203. PubMed ID: 18546073
[TBL] [Abstract][Full Text] [Related]
17. Optimal prescription method for cancer chemotherapy.
Vriesendorp HM
Exp Hematol; 1985; 13 Suppl 16():57-63. PubMed ID: 3857184
[TBL] [Abstract][Full Text] [Related]
18. [Glomerular filtration rate prediction formulas in obese persons with chronic renal impairment].
Schück O; Teplan V; Skibová J; Stollová M
Cas Lek Cesk; 2006; 145(10):772-6. PubMed ID: 17121068
[TBL] [Abstract][Full Text] [Related]
19. Obesity in pediatric oncology.
Rogers PC; Meacham LR; Oeffinger KC; Henry DW; Lange BJ
Pediatr Blood Cancer; 2005 Dec; 45(7):881-91. PubMed ID: 16035086
[TBL] [Abstract][Full Text] [Related]
20. Body surface area for adjustment of drug dose.
Drug Ther Bull; 2010 Mar; 48(3):33-6. PubMed ID: 20200147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
